Skip to search formSkip to main contentSkip to account menu

Vaccines

Known as: VaccineEntityType, [IM100] VACCINES, vaccine product 
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio… 
National Institutes of Health

Related topics

Related topics

43 relations

Narrower (22)

0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled SyringeAdenovirus Type 4 Vaccine Live 32000 UNT Delayed Release Oral TabletBM86 protein, Boophilus

Broader (3)

Biological FactorsBiological ProductsImmunologic Factors
In BloodLot number:ID:Pt:Vaccine:NomManufacturer name:ID:Pt:Vaccine:NomPolysaccharide Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
COMPARATIVE EFFICACY OF PESTE DES PETITS RUMINANTS (PPR) VACCINES AVAILABLE IN PAKISTAN IN SHEEP AND GOATS
The efficiency of Peste des petits ruminants virus (PPRV) vaccines available in Pakistan was evaluated on the basis of the… 
Review
2008
Review
2008
T-cell quality in memory and protection: implications for vaccine design
Nature Reviews Immunology 8, 247–258 (2008) In Figure 5b and Figure 5c, the terms “high” and “low” were reversed. A corrected… 
2006
2006
Regulating effects of novel CpG chitosan-nanoparticles on immune responses of mice to porcine paratyphoid vaccines.
OBJECTIVE To study the regulating effects of a novel CpG oligodeoxynuleotide and the synergistic effect of chitosan-nanoparticles… 
1985
1985
A curious histamine-sensitizing activity shown by the newly-developed Japanese acellular pertussis vaccine.
A new acellular pertussis vaccine, whose official name is "Precipitated Purified Pertussis Vaccine" (PPV), was prescribed in the… 
1984
1984
Properties of cross-linked toxoid vaccines made with hyperantigenic forms of synthetic Escherichia coli heat-stable toxin
The ability of hyperantigenic preparations of synthetically produced Escherichia coli heat-stable toxin (ST) to provide an… 
Review
1983
Review
1983
Synthetic peptide immunogens as vaccines.
Synthetic peptide immunogens have been shown to elicit antibodies that can react with full-length proteins containing that… 
1978
1978
Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
In general, hemagglutination-inhibiting (HAI) and neutralizing (NT) antibodies to rubella virus tend to parallel one another, and… 
Review
1973
Review
1973
Mass vaccination programs in developing countries.
Immunization programs have been demonstrated to be efficient and relatively inexpensive methods of disease prevention in both… 
1973
1973
Trials of aqueous killed influenza vaccine in Canada, 1968-69.
The appearance of the pandemic A/Hong Kong/1/68 (H3N2) influenzavirus strain provided an opportunity for a clinical field trial… 
1972
1972
Synthetic vaccines--a dream or reality.
A great deal of information has been presented at this conference concerning vaccination and vaccines. This has included…